PAR 5.77% 24.5¢ paradigm biopharmaceuticals limited..

Ann: Entitlement Offer and Placement Prospectus, page-10

  1. 1,216 Posts.
    lightbulb Created with Sketch. 1375
    In all fairness do you not think it is better to vote yes given that this is based on future performance metrics? Shouldn't we be providing an incentive for PR and DS to achieve the stated objectives? As you would know I've been very critical of PR, but I think voting no will be a mistake given the next 12 months will be vital to PAR's success.
    Last edited by Zenox: 30/10/23
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.015(5.77%)
Mkt cap ! $85.70M
Open High Low Value Volume
26.0¢ 26.0¢ 24.5¢ $265.4K 1.050M

Buyers (Bids)

No. Vol. Price($)
8 130186 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 11571 1
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.